ATL, I believe that your correct, the question in my mind is, after approval, does NWBO use improved versions of the vaccine in all future trials, or must they use the current version in confirmational trials.
If they must treat the boosting agents like a new vaccine I suspect that the regulators will insist that different trials be done with new and old formulas.
Gary
Market Data 
Markets 
AI
